Kathryn Fitch, RN, MEd

Articles by Kathryn Fitch, RN, MEd

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL

ByKathryn Fitch, RN, MEd,Michael Kolodziej, MD, FACP

March 10th 2022

The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64

ByKathryn Fitch, RN, MEd,Bruce Pyenson, FSA, MAAA,Helen Blumen, MD, MBA,Thomas Weisman, MD, MBA,Art Small, MD

August 5th 2015

Screening commercially insured individuals for colorectal cancer is a high-value service, costing less per year of life saved than breast or cervical cancer screening.

Latest Updated Articles

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL
Published: March 10th 2022 | Updated:
The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64
Published: August 5th 2015 | Updated:

Kathryn Fitch, RN, MEd

Articles by Kathryn Fitch, RN, MEd

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL

The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64

Latest Updated Articles

Trending on AJMC

Congress Unveils Massive Funding Bill to Avert Shutdown

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

Novel CLL Therapies Prompt New Treatment Considerations

Early Data Show Feasibility of in Vivo CAR T Therapy in Multiple Myeloma

Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care